Boulder, Colo.-based Proligo, under license from Danish biotech firm Exiqon, is now marketing a novel class of nucleic acid analogs called locked nucleic acids (LNA™). Sporting increased thermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback